Advertisement

Immunohämatologie der Thrombocyten und Leukocyten

  • P. Miescher
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 7)

Zusammenfassung

Ursprünglich verstand man unter Immunohämatologie in erster Linie die Lehre von den gegen die Erythrocyten gerichteten Immunoreaktionen. Durch die stetige Zunahme von Leukopenien und Thrombopenien infolge medikamentöser Überempfindlichkeit schenkte man allmählich auch den gegen Thrombocyten und Leukocyten gerichteten Immunoreaktionen vermehrte Beachtung. Aber erst durch die Forschung der letzten fünf Jahre gewannen die Leukocyten und Thrombocyten dieselbe Bedeutung in der Immunohämatologie wie die Erythrocyten. Die Fülle der Ergebnisse dieses neuen Forschungszweiges rechtfertigt, dieses Kapitel abgefaßt zu haben. Es soll der heutige Stand unserer Kenntnisse auf diesem Gebiet dargelegt werden. Die Aufgabe wird uns erleichtert durch das von P. Petbides im 4. Band der Ergebnisse der Inneren Medizin vor drei Jahren geschriebene Kapitel. über die pathogenetische Bedeutung der Allergie für Blut- und Knochenmarks-Schäden. Die vorliegende Arbeit soll nicht eine Wiederholung jener Monographie werden, sondern vor allem die inzwischen erzielten Ergebnisse gebührend berücksichtigen. Bezüglich der ausgedehnten, älteren Literatur verweisen wir deshalb auf die Arbeit von P. Petrides.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

1. Allgemeiner Teil und Immunohämatologie der Thrombocyten

  1. Achard, Ch., et M. Aynaud: Les globulins dans l’anaphylaxie. C. r. Soc. Biol. (Paris) 61, 83 (1909).Google Scholar
  2. Ackboyd, J. F.: The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. Clin. Sci. 7, 249 (1948).Google Scholar
  3. Ackboyd, J. F.: The mechanism of the reduction of clot retraction by sedormid in the blood of patients who have recovered from sedormid purpura. Clin. Sci. 8, 235 (1949).Google Scholar
  4. Ackboyd, J. F.: The cause of thrombocytopenia in sedormid purpura. Chn. Sci. 8, 269 (1949).Google Scholar
  5. Ackboyd, J. F.: The role of complement in sedormid purpura. Clin. Sci. 10, 185 (1951).Google Scholar
  6. Ackboyd, J. F.: The immunology of drug-induced purpura. 1. Symposium della fondazione Valentino Baldacci. Madrid, 27—28 maggio, 1955.Google Scholar
  7. Ackboyd, J. F.: Thrombocytopenic purpura due to hypersensitivity to the antihistaminic drug antazoline. Sang 26, 115 (1955).Google Scholar
  8. Ackboyd, J. F.: Three cases of thrombocytopenic purpura occurring after rubella. Quart. J. Med. 72, 299 (1949).Google Scholar
  9. Adamson, D. G., W. Walker and A. E. MacIntosh: ACTH and cortisone in ITP and Schön- lein-Henoch purpura. Brit. Med. J. 1953 II, 656.Google Scholar
  10. Adelson, E., and M. Stefanini: Studies on Platelets VI: Demonstration and characterization of a heterologous platelet agglutinin. Blood 7, 700 (1952).PubMedGoogle Scholar
  11. Adelson, E., E. J. Heitzman and J. F. Fennessey: Thrombohämolytische thrombopenische Purpura. Arch. Int. Med. 94, 42 (1954).Google Scholar
  12. Äkerren, Y., and T. Reinand: Thrombocytopenia in the new-born-period. Acta med. scand. (Stockh.) Suppl. 246, 281 (1950).Google Scholar
  13. Albertini, A. von: Bedeutung der Allergielehre für die Pathologie. Schweiz. Z. allg. Path. 17, 1 (1954).Google Scholar
  14. Allegri, A., e V. Ferrari: Esperienze cliniche con al 5-ossi-triptamina in alcune forme di diatesi emorragica. Minerva med. (Torino) 1954, No. 101.Google Scholar
  15. Aufdermauer, A., u. W. Meyer: Immunohämatologische Untersuchungen bei Morbus Werlhof. Kasuistische Mitteilung. Helvet. med. Acta 22, 446 (1955).Google Scholar
  16. Bamforth, J., and J. St. G. Elkington: Arsenobenzol purpura, with a short description of 4 cases. Quart. J. Med. 24, 381 (1931).Google Scholar
  17. Barkham, P., and M. Tocantins: Observations on the thrombocytopenia due to hypersensitivity to quinme. Blood 9, 308 (1937).Google Scholar
  18. Baserga, A., et G. Ballerini: La 5-hydroxytryptamine dans la thérapie des hémorragies thrombocytopéniques. Schweiz, med. Wschr. 1955, 914.Google Scholar
  19. Bedson, S. PH.: Blood Platelet anti-serum; its specificity and role in the experimental production of purpura. J. of Path. 24, 469 (1921); 25, 94 (1922).Google Scholar
  20. Bedson, S. Ph. and M. E. Johnston: Further observations on platelet genesis. J. of Path. 28, 101 (1925).Google Scholar
  21. Beiglböck, W.: Ein Fall von thrombopenischer Purpura bei echter Chininüberempfindlichkeit. Z. khn. Med. 131, 308 (1937).Google Scholar
  22. Bell, W. N., and H. G. Alton: A study of platelet numbers and function in splenic arterial and venous blood in hypersplenic syndromes and the normal. Acta haematol. (Basel) 13, 1 (1955).Google Scholar
  23. Benhamoij, E., B. Ferrand et P. Griguer: Purpura thrombocytopénique aigu avec auto- anticorps traité par la cortisone. Algérie méd. 58, 319 (1954).Google Scholar
  24. Berger, H.: Thrombopenic purpura following use of digitoxin. J. Amer. Med. Assoc. 148, 282 (1952).Google Scholar
  25. Bianchi, A. E.: Consideraciones sobre un caso de purpura. Rev. Asoc. med. argent. 46. 1566 (1932).Google Scholar
  26. Bigelow, F. S., and J. F. Desforges: Platelet agglutination by an abnormal plasma factor in thrombocytopenic purpura associated with quinidine ingestion. Amer. J. Med. Sci. 224, 274 (1952).PubMedGoogle Scholar
  27. Birkenhäger, W. H.: Cas de purpura thrombopénique aigu du a plusieurs agents tuberculostatiques au cours prolongé. Sang 26, 137 (1955).PubMedGoogle Scholar
  28. Birkenhäger, W. H.: Un cas de purpura thrombopénique aigu après I’administration de streptomycine et d’INH. Vox Sanguinis 4, 167 (1954).Google Scholar
  29. Bloom, G., K. H. Gustavson and A. Swensson: On the reaction of the thrombocytes to submicroscopic particles in vitro. Acta haematol. (Basel) 13, 57 (1955).Google Scholar
  30. Bolton, E. T., C. A. Leone and A. A. Boyden: A critical analysis of the performance of the photronreflectometer in the measurement of serological and other turbid systems. J. of Immun. 58, 169 (1948).Google Scholar
  31. Bolton, E. T., and R. V. Young: Observations on cases of thrombocytopenic purpura due to quinine, sulphamezathine, and quinidine. J. Chn. Path. 6, 320 (1953).Google Scholar
  32. Boyden, A. A., E. T. Bolton and D. Gemeroy: Precipitin testing with special reference to the photoelectric measurement of turbidity. J. of Immun. 57, 211 (1947).Google Scholar
  33. Bracco, M., P. C. Curtí e G. Ballerini: Azione del fattore vasocostrittore piastrinico suUa resistenza capillare. Farmaco 9, No. 5 (1954).Google Scholar
  34. Braunsteiner, H., u. F. Pakesch: Elektronenmikroskopische Untersuchung der Wirkung eines starken Plättchenagglutinins bei essentieller Thrombopenie auf normale Plättchen. Klin. Wschr. 1954, 79.Google Scholar
  35. Bukantz, S. CH., A. Cooper and J. G. M. Bullowa: The photoelectric titration of pneumococcal capsular polysaccharide. J. Bacter. 42, 15 (1941).Google Scholar
  36. Chauffard, A., et J. Troisier: Anémie grave avec hémolysine dans le sérum. Sem. méd. Paris 28, 345 (1908);Google Scholar
  37. Chauffard, A.: Contribution à l’étude des hémolysines dans leur rapport avec l’anémie grave. Bull. Soc. Méd. Hôp. Paris, 26, 94 (1908).Google Scholar
  38. Cole, R. I.: Note on the production of an agglutinating serum for blood platelets. Johns Hopkins Hosp. Bull. 18, 261 (1907).Google Scholar
  39. Cooper, T., J. M. Stickney, G. L. Pease and W. A. Bennett: Thrombotic thrombocytopenic purpura. Confirmation of chnical diagnosis by bone marrow aspiration. Amer. J. Med. 13, 3 (1952).Google Scholar
  40. Dameshek, W., and M. Stefanini: ITP: Some ideas on its pathogenesis and treatment. Med. Clin. N. Amer. 37, 1395 (1953).Google Scholar
  41. Dameshek, W., and E. B. Miller: The Megakaryocytes in ITP, a form of hypersplenism. Blood 1, 27 (1946).PubMedGoogle Scholar
  42. Dausset, J., P. Delafontaine et Y. Fleuriot: Agglutination et destruction in vitro des plaquettes normales par le sérum d’une malade atteinte de purpura thrombopénique aigu. Inhibition parce sérum de la rétraction du caillot normal. Sang 23, 373 (1952); Semaine Hôp. 1953, 1334.PubMedGoogle Scholar
  43. Dausset, J., et G. Malinvaud: Normal and pathological platelet agglutinins investigated by means of the shaking method. Vox Sanguinis 4, 204 (1954).Google Scholar
  44. Dausset, J.,: Influence de l’agitation sur l’agglutination thrombocytaire. Son utihté pour la recherché des thrombo-agglutinines et dans la pratique du test de Coombs plaquettaire. Sang 25, 847 (1954).PubMedGoogle Scholar
  45. Dausset, J., et F. Layani: Purpura thrombopénique aigu au phényl-diméthyl-isopropyl-pyrazolone. Semaine Hôp. 1954, 3055.Google Scholar
  46. Dausset, J., B. Bilski-Pasquier, G. Malinvaud, R. J. Davy et ST. Tara: Syndromes hémorragiques par sensibihsation médicamenteuse. Sang 25, 911 (1954).PubMedGoogle Scholar
  47. Dennig, H.: Thrombopenische Purpura nach Jodeinnahme. Münch, med. Wschr. 1933, 562.Google Scholar
  48. Doan, C. A.: Hypersplenism. Bull. New York Acad. Med. 25, 625 (1949).Google Scholar
  49. Dennig, H., G. M. Curtis and B. K. Wiseman: The hemolytopoietic equihbrium and emergency splenectomy. J. Amer. Med. Assoc. 105, 1567 (1935).Google Scholar
  50. Donath, J., u. K. Landsteiner: Über paroxysmale Hämoglobinurie. Münch, med. Wschr, 1904, 1590.Google Scholar
  51. Dutton, L. O.: Thrombopenie purpura due to food allergy. J. Amer. Med. Assoc. III, 1920 (1938).Google Scholar
  52. Ecejlebe, G., u. K. Sander: Der Ablauf der Immunoreaktionen unter ACTH bei experimenteller hämolytischer Anämie. Z. exper. Med. 119, 388 (1952).Google Scholar
  53. Ehrlich, P.: Die Schutzstoffe des Blutes. Dtsch. med. Wschr. 1901, 913.Google Scholar
  54. Epstein, R. D., E. L. Lozner, TH. S. Cobbey and C. S. Davidson: Congenital thrombocytopenic purpura. Purpura hemorrhagica in pregnancy and in the newborn. Amer. J. Med. 9, 44 (1955).Google Scholar
  55. Evans, R. S., and R. T. Duane: Acquired Hemoljrtic Anemia. The significance of thrombocytopenia and leukopenia. Blood 4, 1196 (1949).PubMedGoogle Scholar
  56. Evans, R. S., K. Takahashi, R. T. Duane, R. Payne and Liu Chi-Kong: Primary thrombocytopenic purpura and acquired hemolytic anemia. Evidence for a common etiology. Arch. Int. Med. 87, 48 (1951).Google Scholar
  57. Evans, R. S., and L. Chi-Kong: Effect of ACTH on chronic, severe primary thrombocytopenic purpura. Arch. Int. Med. 88, 503 (1951).Google Scholar
  58. Falconer, E. H., and I. C. Schumacher: Purpura hemorrhagica due to ingestion of sedormid. Arch. Int. Med. 65, 122 (1940).Google Scholar
  59. Faloon, W. W., R. W. Greene and E. L. Lozner: The hemostatic defect in thrombocytopenia as studied by the use of ACTH. Amer. J. Med. 13, 12 (1952).PubMedGoogle Scholar
  60. Fidlar, E., and E. T. Waters: The behaviour of platelets in anaphylactic and peptone shock. J. of Immun. 52, 315 (1946).Google Scholar
  61. Flückiger, P., A. Hässig u. F. Koller: Über den Thrombocyten-Coombs-Test. Schweiz, med. Wschr. 1953, 1035; Acta haematol. (Basel) 12, 339 (1954).Google Scholar
  62. Frank, E.: Die essentielle Thrombopenie (Konstitutionelle Purpura Pseudo-Hämophilie). 1.Klinisches Büd. Beri. klin. Wschr. 1915, 454; II. Pathogenese. Beri. klin. Wschr. 1915, 490.Google Scholar
  63. Gardner, F. H., D. Howell and E. O. Hirsch: Platelet transfusions utilizing plastic equipment. J. Labor, a. Clin. Med. 43, 196 (1954).Google Scholar
  64. Gblin, G.: Purpuras thrombocytopéniques aigus traités par la cortisone. Acta haematol. (Basel) 13, 298 (1955).Google Scholar
  65. Gendel, B. R., J. M. Young and A. P. Kraus: Thrombotic thrombocytopenic purpura. Amer. J. Med. 13, 3 (1952).PubMedGoogle Scholar
  66. Gennerich, H.: Die Blutgruppenspezifität der Thrombocyten. Inaugural-Dissertation unter Leitung von R. Jürgens. Berlin 1938.Google Scholar
  67. Gitlin, D., and H. Edelhoch: A study of the reaction between human serum albumin and its homologous equine antibody through the mediiun of Hght scattering. J. of Immun. 66, 67 (1951).Google Scholar
  68. Goldberg, R. J., and D. H. Campbell: The Hght scattering properties of an antigen-antibody reaction. J. of Immun. 66, 79 (1951).Google Scholar
  69. Grandjean, L. C.: A case of purpura hemorrhagica after administration of quinine with specific thrombolytolysis demonstrated in vitro. Acta med. scand. (Stockh.) 131, suppl. 213, 165 (1948).Google Scholar
  70. Gugudda, E., e C. Pirastu: Dimostrazione di un „Fattore Plasmático Thrombopenizzante” in un caso di thrombopenia idiopatica di Werlhof. Settimana med. 40, 46 (1952)Google Scholar
  71. Gurevitch, J., and D. Nelken: ABO groups in blood platelets. Sang 26, 113 (1955); Nature (London) 173, 356 (1954); Acta med. orient. 14, 44 (1955); J. Labor, A. Clin. Med. 44, 562 (1954).PubMedGoogle Scholar
  72. Gurevitch, J., and D. Nelken: Elution of isoagglutinins adsorbed by platelets. Nature (London) 175, 822 (1955).Google Scholar
  73. Harrington, W. J., J. W. Hollingsworth and C. V. Moore: Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J. Labor, a. Clin. Med. 38, 1 (1951).Google Scholar
  74. Harrington, W. J., C. C. Sprague and R. D. Lange: Platelet transfusion and the pathogenesis of ITP. J. Amer. Med. Assoc. 150, 1193 (1952).Google Scholar
  75. Harrington, W. J.: The clinical significance of antibodies for platelets. Sang 25, 712 (1954).PubMedGoogle Scholar
  76. Harrington, W. J., Ch. C. Sprague, V. Minnich, C. V. Moore, R. C. Aulvin and R. Dubach: Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann. Int. Med. 38, 433 (1953).PubMedGoogle Scholar
  77. Hävermark, N. G., and N. G. Nordenson: The effect of ACTH and Cortisone on hemorrhagic diathesis with thrombocytopenia. Acta haematol. (Basel) 9, 107 (1953).Google Scholar
  78. Hirsch, E. O., and F. H. Gardner: The life span of transfused human blood platelets. J. Clin. Invest. 30, 649 (1951).Google Scholar
  79. Hirsch, E. O.: The transfusion of human blood platelets. J. Labor, a. Clin. Med. 39, 556 (1952).Google Scholar
  80. Hirsch, E. O., and W. Dameshek: “Idiopathic” thrombocytopenia: Review of eighty-nine cases with particular reference to the differentiation and treatment of acute (self-Hmited) and chronic types. Arch. Int. Med. 88, 701 (1951).Google Scholar
  81. Hirsch, E. O., and W. Dameshek: Thrombocytopenic purpura due to aUergy to quinidine. Study of the mechanism of thrombocytopenia. Amer. J. Med. 9, 828 (1950).PubMedGoogle Scholar
  82. Hoigne, R., u. H. Storck: Über die Bedeutung der Thrombocytentest bei allergischen Vorgängen. 2. Mitteilung. Thrombocytenagglutination in Patientenblut nach Zugabe von Allergen. Schweiz, med. Wschr. 1953, 718.Google Scholar
  83. Hoigne, R., H. Frei u. H. Storck: Über die Bedeutung der Thrombocytentest bei allergischen Vorgängen. 3. Mitteilung. Tierexperimentelle Untersuchungen zur Frage des Antikörpergehaltes der Thrombocyten. Schweiz, med. Wschr. 1953, 712.Google Scholar
  84. Hoigne, R., P. Flückiger, H. Storck u. F. Koller: 4. Mitteilung. Thrombocytentest „in vitro” in Fällen von medikamentöser Allergie. Schweiz, med. Wschr. 1954, 1168.Google Scholar
  85. Hoigne, R., A. Loeliger, L. Morandi u. P. Flückiger: Thrombocytopenische Purpura bei drei Fällen von medikamentöser Allergie. Bull. Schweiz. Akad. Med. Wiss. 10, 438 (1954).PubMedGoogle Scholar
  86. Hoigne, R., W. Grossmann u. H. Storck: Neue serologische Methode zum Nachweis von Sensibilisierungen auf Allergene, Methodikimd erste klinische Erfahrung. Schweiz, med. Wschr. 1955, 578.Google Scholar
  87. Jacobson, B. M., and W. D. Sohier: Effects of ACTH and Cortisone on the platelets in ITP. New England J. Med. 246, 247 (1952).Google Scholar
  88. Jones, D. T., and J. L. Jacobs: The treatment of obstinate chorea with nirvanol, with notes on its mode of action. J. Amer. Med. Assoc. 99, 18 (1932).Google Scholar
  89. Katsura, H.: Untersuchungen über die experimentelle Purpura haemorrhagica beim Meerschweinchen. Purpura haemorrhagica verursacht durch Hämangioendotheliotoxin. Trans. Japan. Path. Soc. 14, 152 (1924).Google Scholar
  90. Kaznelson, P.: Verschwinden der hämorrhagischen Diathese bei einem Falle von „essentieller Thrombopenie“ nach Milzexstirpation. Splenogene thrombolytische Purpura. Wien. Min. Wschr. 1916, 1451.Google Scholar
  91. Kaznelson, P.: Thrombolytische Purpura. Z. Min. Med. 87, 133 (1919).Google Scholar
  92. Keibl, E.: Cortisonwirkung bei Thrombopenien. Wien. Min. Wschr. 1953, 503.Google Scholar
  93. Keiser, D. P. R.: Purpura hemorrhagica as a sequence of measles. Nederl. Tijdschr. Geneesk. 1947, 1482.Google Scholar
  94. Kerr Grant, D.: Diagnosis of sedormid purpura. Brit. Med. J. 2, 128 (1953).Google Scholar
  95. Kiep, I. C.: Akute Thrombopenie als medikamentaUergische Reaktion gegen Pyramiden und Marbadal. Dtsch. med. Wschr. 1952, 9; Allergiebeilage 1.Google Scholar
  96. Kissmeyer-Nielseh, F.: Demonstration of platelet antibodies by haemagglutination of antigen coated tanned erythrocytes. Vox Sangumis 3, 123 (1953); Sang 26, 117 (1955); Fol. Clin. Internacional 4, No. 11 (1954).Google Scholar
  97. Kissmeyer-Nielseh, F.: Immuno-hämatologisches Kolloquium, Freiburg i. Br. (Europ. Hämatologenkongreß, September 1955).Google Scholar
  98. Köhn, K.: Zur Kenntnis der thrombotischen thrombocytopenischen Purpura. Dtsch. med. Wschr. 1955, 573.Google Scholar
  99. Komrower, G. M., and G. H. Watson: Prognosis in ITP of Childhood. Arch. Dis. Chüdh. 29, 502 (1954).Google Scholar
  100. Kopelopf, N., and L. M. Kopelopf: Blood platelets in anaphylaxis. J. of Immim. 40, 471 (1941).Google Scholar
  101. Landsberger, M.: Ein Fall von KuhmUchintoleranz beim Säughng mit Purpura. Z. Kinderheilk. 39, 569 (1925).Google Scholar
  102. Landolt, R. F.: Kongenitale Thrombopenien. Helvet. paediatr. Acta 3, 3 (1948).Google Scholar
  103. Landsteiner, K.: The specificity of serological Reactions. London: Oxford Univ. Press 1944.Google Scholar
  104. Larson, R. K.: The mechanism of quinidine purpura. Blood 8,16 (1953).PubMedGoogle Scholar
  105. Libby, R. L.: The photronreflectometer. An instrument for the measurement of turbid systems. J. of Immun. 34, 71 (1938).Google Scholar
  106. Loghem, J. J. van: Immunohämatologisches Kolloquium, Paris, Januar 1955.Google Scholar
  107. Lozner, E. L.: Differential Diagnosis, Pathogenesis and Treatment of the thrombocytopenic purpuras. Amer. J. Med. 14, 459 (1953).PubMedGoogle Scholar
  108. Lozner, E. L.: The thrombocytopenic purpuras. Bull. New York Acad. Med. 30, 184 (1954).Google Scholar
  109. Maritschek, M., u. H. Markowicz: Über einen Fall von Chininüberempfindhchkeit mit Purpura, vorwiegend der oberen Luft- und Speisewege. Mschr. Ohrenheilk. 67, 410 (1933).Google Scholar
  110. Magnusson, J. H.: Acute Thrombocytopenic purpura foUowing rubella. Acta med. scand. (Stockh.) 126, 40 (1947).Google Scholar
  111. Malinvaud, G., J. Dausset et F. Layani: Purpura thrombopénique aigu aux dérivés de l’antipyrine. Sang 26, 130 (1955).PubMedGoogle Scholar
  112. Malinvaud, G., J. Dausset et F. Layani: Etudes sur les thromboagglutinines au moyen de la méthode d’agitation. Sang 26, 123 (1955).PubMedGoogle Scholar
  113. Mannheimer, E., E. E. Reimer u. E. Windhager: Immunothrombopenie mit akutem Verlauf. Wien. Z. inn. Med. 35, 493 (1954).PubMedGoogle Scholar
  114. Marino, M. F.: Recherches sur les plaquettes du sang. C. r. Soc. Biol. (Paris) 58, 194 (1905).Google Scholar
  115. Martin, D. S.: Use of the photronreflectometer for determination of the optimal ratio between pneumococcus type I SSS and antipneumococcus type I rabbit serum. J. Labor, a. Clin. Med. 28, 870 (1943).Google Scholar
  116. Maupin, B., et R. Chary: Présentation d’ime nouveUe méthode de séparation des leucocytes et des plaquettes sanguines. Sang 23, 336 (1952).PubMedGoogle Scholar
  117. Maupin, B.: Les plaquettes sanguines de l’homme. Paris: Masson & Cie. 1954.Google Scholar
  118. Maupin, B.: L. Berroche et P. Hervier: Immunohämatologisches KoUoquium, Europ. Hämat. Kongreß, Freiburg i. Br. 1955.Google Scholar
  119. Mc Carthy, F. P., and R. Wilson: The blood dyscrasias following arsphenamines. J. Amer. Med. Assoc. 99, 1557 (1932).Google Scholar
  120. Metalnikopf, S.: Etudes sur la spermatoxine. Ann. Inst. Pasteur 14, 577 (1900).Google Scholar
  121. Meyer, W., B. Wuilleret u. A. Hässig: Über den Nachweis von Blutgruppenantigenen in Thrombocyten. Z. Immun.forsch. (im Druck.)Google Scholar
  122. Miescher, P.: NouveUes acquisitions dans les réactions immunologiques concernant les leucocytes et les plaquettes. Schweiz, med. Wschr. 1953, 1185.Google Scholar
  123. Miescher, P.: Immunothrombopenien. Hämorrhagische Diathesen, Internat. Symposion, Wien 1955, S. 37. Wien: Sprmger-Verlag 1955.Google Scholar
  124. Miescher, P., S. Cruchaud et G. Hemmeler: NouveUes acquisitions concernant la pathogénèse de la thrombocytopénie essentielle. Helvet. med. Acta 19, 434 (1952).PubMedGoogle Scholar
  125. Miescher, P., A. Vannotti, S. Cruchaud u. G. Hemmeler: Die Pathogenese der essentiellen Thrombocytopenie. J. of Exper. Med. 10, 265 (1952).Google Scholar
  126. Miescher, P., u. A. Miescher: Die Sedormid-Anaphylaxie. Schweiz, med. Wschr. 1952, 1279.Google Scholar
  127. Miescher, P., u. O. Rittbe: Purpura thrombopénique par allergie à la digitoxine. Internat. Arch. Allergy 4, 253 (1953).Google Scholar
  128. Miescher, P., u. A. Vannotti: Leucoet thrombopénie par «auto-anticorps». Bull. Acad. Suisse Sci. Med. 10, 85 (1954).Google Scholar
  129. Miescher, P., R. Stbabssle et S. Neukomm: Etude de la réaction antigène-anticorps dans le sang au moyen d’un antigène marqué. Helvet. med. Acta 21, 392 (1954).PubMedGoogle Scholar
  130. Miescher, P., A. Reymond et A. Vannotti: Thrombopénies thromboclastiques. J. of Exper. Med. 12, 501 (1954).Google Scholar
  131. Miescher, P., R. Strabssle et A. Mibscher: Etude expérimentale du mécanisme des cytopénies anaphylactiques. Sang 26, 76 (1955).PubMedGoogle Scholar
  132. Miescher, P. et A. Hässig: Localisation des «auto-anticorps» érythrocytaires, leucocytaires et plaquettaires dans les fractions plasmatiques de Cohn. Internat. Kongress Ges. für Bluttransfusion, Paris, 1954.Google Scholar
  133. Moeschlin, S.: Die Sedormid-Thrombocytopenie an Hand von Stemalpunktaten, Belastungs- und Transfusionsversuchen. Schweiz. Wschr. 1942, 119.Google Scholar
  134. Moolten, S. E.: Studies on extractable factors in the spleen and other organs which influence the blood platelet count. J. Moimt Sinai Hosp. 12, 866 (1945).Google Scholar
  135. Morris, B.: Thrombocytopenic purpura in the newborn. Arch. Dis. Chüdh. 29, 75 (1954).Google Scholar
  136. Moulioter, J.: Test de Consommation d’antiglobuline appliqué à la recherche des anticorps anti-thrombocytes. Sang (im Druck).Google Scholar
  137. Moulioter, J., et F. Mesmer: Use of Mpoid platelet extracts in the agglutination reaction of sensitized particles. Vox Sanguinis 4, 199 (1954).Google Scholar
  138. Moureau, P., et A. André: Présence des antigènes A. et B. dans les plaquettes. Vox Sanguinis 4, 46 (1954).Google Scholar
  139. Naegeli, O.: Differentialdiagnose in der Inneren Medizin. Leipzig: Georg Thieme 1937.Google Scholar
  140. Neville, M. L., and L. M. Mastbrman: Neonatal Thrombocytopenic purpura in two infants. Arch. Dis. Chüdh. 29, 163 (1954).Google Scholar
  141. Paul, J. T.: The effect of splenic extracts from cases of essent. thrombocytopenic purpura on the platelets and hematopoietic organs of rabbits. J. Labor, a. Clin. Med. 27, 745 (1942).Google Scholar
  142. Petrides, P.: Die Pathogenetische Bedeutung der AUergie für Blut- und Kaochenmarks-schäden. Erg. inn. Med. 4, 195 (1953).Google Scholar
  143. Pisciotta, A. V., M. Stefanini and W. Dambshek: Studies on Platelet X. Blood 8, 703 (1953).PubMedGoogle Scholar
  144. Pope, C. G., and M. Healey: A photoelectric study of reaction between diphtheria toxin and antitoxin. Brit. J. Exper. Path. 19, 397 (1938).Google Scholar
  145. Porter, R. R.: The formation of a specific inhibitor by hydrolysis or rabbit antiovalbumin. Biochemic. J. 46, 479 (1950).Google Scholar
  146. Reimer, E. E., E. Mannheimer u. E. Windhager: Beitrag zur Thrombocytengruppenbestimmung. Hämorrhagische Diathesen, Int. Symposion, Wien 1955, S. 49. Wien: Springer. Verlag 1955.Google Scholar
  147. Robson, H. N., and C. H. M. Walker: Congenital and Neonatal Thrombocytopenic purpura. Arch. Dis. Chüdh. 26, 175 (1951).Google Scholar
  148. Rocha, E. Silva, M.: The role played by leucocytes and platelets in anaphylactic and peptone shock. Ann. N. Y. Acad. Sci. 50, 1045 (1950).Google Scholar
  149. Saint-Paul, M., P. Millot u. A. Eyquem: Immunologie der gegen die Thrombocyten gerichteten Antikörper. Europ. Hämat. Kongreß, Freiburg i. Br., 1955.Google Scholar
  150. Sauer, A. J., et J. J. van Loghem: A study on the occurrence of platelet antibodies.Vox. Sanguinis 4, 120 (1954).Google Scholar
  151. Schoch, A.: Über die Entwicklimg und Erprobung des Hämostyptikums „Tachystyptan“. Ther. Umschau 12,26 (1955).Google Scholar
  152. Sprague, C. H. C., W. J. Harrington, R. D. Lange and J. B. Shapleigh: Platelet transfusions and the pathogenesis of ITP. J. Amer. Med. Assoc. 150, 1193 (1952).Google Scholar
  153. Stefanini, M., and J. H. Silverberg: Studies on platelets I. Amer. J. Clin. Path. 21, 1030 (1951).Google Scholar
  154. Stefanini, M., and J. B. Chatterjea: Rate of platelet survival in thrombocytopenia. J. Clin. Invest. 30, 676 (1951).Google Scholar
  155. Stefanini, M., J. B. Chatterjea and E. Adelson: Immunologic aspects of ITP. J. Clin. Invest. 31, 665 (1952).Google Scholar
  156. Stefanini, M., W. Dameshek, L. Zannos and E. P. Santiago: Studies on platelets II. Blood 7, 53 (1952).PubMedGoogle Scholar
  157. Stefanini, M., W. Dameshek., L. Zannos, C. S. Welch and O. Swenson: Studies on platelet III. The absence of “selective sequestration” and destruction of platelets by the spleen in ITP. Blood 7, 289 (1952).PubMedGoogle Scholar
  158. Stefanini, M., W. Dameshek, L. Zannos: Studies on platelets IV. Thrombocytopenic factor in normal human blood, plasma or serum. Proc. Soc. Exper. Biol. a. Med. 79, 623 (1952).Google Scholar
  159. Stefanini, M., W. Dameshek: Studies on platelets V. Observations on the removal by the pulmonary circulation of platelets injected into patients with ITP. J. Labor, a. Clin. Med. 39, 865 (1952).Google Scholar
  160. Stepaihni, M., W. Dameshek and E. Adelson: Platelets VII. Shortened “platelet survival time” and development of platelet agglutinins following multiple platelet transfusions. Proc. Soc. Exper. Biol. a. Med. 80, 230 (1952).Google Scholar
  161. Stepaihni, M and E. Adelson: Studies on platelets VIII. Heterophile reaction due to Forssman Antibody in patients with idiopathic and secondary thrombocytopenic purpura. Amer. J. Clin. Path. 22, 1164 (1952).Google Scholar
  162. Stepaihni, M: Recent observations on the pathogenetic mechanism of ITP. J. Mount Sinai Hosp. 19, 452 (1952).Google Scholar
  163. Stepaihni, M., W. Dameshek, J. B. Chatteejea, E. Adelson and I. B. Mednicoff: Studies on platelets IX. Observations on the properties and mechanism of action of a potent platelet agglutinin detected in the serum of a patient with ITP. Blood 8, 26 (1953).Google Scholar
  164. Stepaihni, M: Studies on platelets XIII. Sang 26, 83 (1955).Google Scholar
  165. Stepaihni, M: Management of thrombocytopenic states. Arch. Int. Med. 95, 543 (1955).Google Scholar
  166. Stepaihni, M., E. Perez-Santiago, J. B. Chatterjea, W. Dameshek and L. Salomon: Corticotrophin and cortisone in ITP. J. Amer. Med. Assoc. 149, 647 (1952).Google Scholar
  167. Stepaihni, M and W. Dameshek: Collection, preservation and transfusion of platelets. New England J. Med. 248, 797 (1953).Google Scholar
  168. Stepaihni, M., G. I. Plitman, W. Dameshek, J. B. Chatterjea and I. B. Mednicoff: Studies on platlets XI. Antigenicity of platelets and evidence of platelet groups and types in man. J. Labor, a. Clin. Med. 42, 273 (1953).Google Scholar
  169. Stepaihni, M., G. I. Plitman: Antigenicity of platelets and evidence for platelets groups in humans. J. Chn. Invest. 32, 606 (1952).Google Scholar
  170. Steffen, C.: Bericht über den Nachweis sessiler Antikörper an Gewebs- und Blutzellen durch Antihumanglobulinablenkung. Klin. Wschr. 1955, 134.Google Scholar
  171. Steffen, C., F. Fessl u. H. Schindler: Untersuchung über den Einfluß von Cortison auf den Ablauf von Antigen-Antikörper- und Autoantikörperreaktionen. Schweiz, med. Wschr. (im Druck).Google Scholar
  172. Steinkamp, R., C. V. Moore and G. Dotjbek: Thrombocytopenic purpura caused by hypersensitivity to quinine. J. Labor, a. Clin. Med. 45, 18 (1955).Google Scholar
  173. Storck, H.: Purpurischer Lupus erythematodes bei Morbus Werlhof. Dermatologica (Basel) 101, 256 (1950).Google Scholar
  174. Storck, H., P. Bigliardi, H. Brenn u. R. Hoigné: Über die Bedeutimg der Thrombocyten bei allergischen Vorgängen. 1. Mitteilung. Thrombocytenabfall in vivo nach Allergenexposition. Schweiz, med. Wschr. 1953, 692.Google Scholar
  175. Storck, H., R. Hoigné u. F. Koller: Thrombocytenabfall als Hilfsmittel zur Allergendiagnose. 1. Internat. Allergiekongreß, Zürich, S. 739. Basel: S. Karger 1951.Google Scholar
  176. Tocantins, L. M.: No platelet-destroying action in extracts of the spleen and urine of patients with chronic thrombopenie purpura. Proc. Soc. Exper. Biol. a. Med. 42, 485 (1939).Google Scholar
  177. Torrioli, M., e V. Puddu: Studio sulla biologia dei megacariociti sopraviventi in vitro. Pohclinico, Sez. med. 41, 245 (1934).Google Scholar
  178. Torrioli, M., e M. Galeazzi: Studi sulla biologia dei megacariociti sopraviventi in vitro: azione di estratti dì musculo e di fegato. Pohchnico, Sez. med. 41, 647 (1934).Google Scholar
  179. Torrioli, M., e V. Puddu: Studi sulla biologia dei megacariociti sopra viventi in vitro: Azione del Sangue venoso splenico. Policlinico, Sez. med. 42, 129 (1935).Google Scholar
  180. Torrioli, M., V. Puddu: Recent studies on the pathogenesis of Werlhof’s Disease. J. Amer. Med. Assoc. 111, 1455 (1938).Google Scholar
  181. Troland, CH., and P. C. Lee: Thrombocytopen, a substance in the extract from the spleen of patients with ITP that reduces the number of blood platelets. J. Amer. Med. Assoc. 111, 221 (1938).Google Scholar
  182. Tzanck, A., et J. Dausset: Immuno-Hématologie et Clinique. Les maladies d’auto-agression. Semame Hôp. 1952, 793.Google Scholar
  183. Uhlenhuth, P. T.: Zur Lehre von der Unterscheidung verschiedener Eiweißarten mit Hüfe spezifischer Sera. Festschr, F., R. Koch, S. 49. Jena: Gustav Fischer 1903.Google Scholar
  184. Uihlein, A.: Effect of injection of tissue extracts on the number of blood platelets. J. Labor, a. Chn. Med. 28, 157 (1942).Google Scholar
  185. Verger, P., J. Bentegeat et D. Dumas: Rôle de la rate dans la genèse des thrombocytes et dans la maturation des mégacaryocytes. Etude expérimentale. Semaine Hôp. 29, 381 (1953).Google Scholar
  186. Verstraete, M., et J. Vandenbroucke: Thrombocytopénies par agglutinines. Revue du problème et présentation de nouveaux cas. Acta haematol. (Basel) 13, 129 (1955).Google Scholar
  187. Watson, G. M.: The blood platelets and splenic extracts. Brit. Med. J. 1941 I, 704.Google Scholar
  188. Weinreich, J.: Die Immunthrombocytopenien. Ein neues Gebiet der Immunohämatologie. Khn. Wschr. 1955, 505.Google Scholar
  189. Weisfuse, L., P. W. Spear and M. Sass: Quinidine-induced thrombocytopenic purpura. Amer. J. Med. 17, 414 (1954).PubMedGoogle Scholar
  190. Werlhof, P. G.: Morbus maculosus haemorrhagicus. Excerpta e Comctnercio Norico, 1731—1745, paragraph 48 (in Opera Medica Pars III, 748, 1776, impensis fratrum Helwingiorum, Hannover).Google Scholar
  191. Widal, F., P. Abrami et M. Brulé: Auto-agglutinations des hématies dans l’ictère hémolytique acquis. C. r. Soc. Biol. (Paris) 64, 655 (1908).Google Scholar
  192. Wilson, S. J., and G. Eisemann: The effect of ACTH and Cortison on ITP. Amer. J. Med. 21, 13 (1952).Google Scholar
  193. Wiseman, B. K., C. A. Doan and S. J. Wilson: The present status of thrombocytopenic purpura with special reference to diagnosis and treatement. J. Amer. Med. Assoc. 115, 8 (1940).Google Scholar
  194. Wright, C. S., C. A. Doan, B. A. Bouroncle and R. M. Zollinger: Direct splenic arterial and venous blood studies in the hypersplenic syndromes before and after epinephrine. Blood 6, 195 (1951).PubMedGoogle Scholar
  195. Zarafonetis, C. J. D., W. A. Steiger and S. K. Cary: Compounds E. and P. and ACTH in the management of ITP. Amer. J. Med. Sci. 228, 1 (1954).PubMedGoogle Scholar

2. Die Immunhämatologie der Leukocyten

  1. Abell, R. G., and H. P. Schenck: Microscopic observations on the behavior of living blood vessels of the rabbit during the reaction of anaphylaxis. J. of Immun. 32, 195 (1938).Google Scholar
  2. Achard, CH., et H. Bénard: Réactions spécifiques des leucocytes. Leuco-Diagnostic. C. r. Soc. Biol. (Paris) 2, 502 (1909).Google Scholar
  3. Achard, C., F. Coste et R. Cahe: Un cas de pure agranulocytose et un cas de purpura hémorragique avec agranulocytose terminale consécutif à un traitement aux sels d’or. Bull. Soc. méd. Hop, Paris 3, 547 (1932).Google Scholar
  4. André, R., B. Dreyfus et M. Bessis: Leucose lymphoide avec leucopénie. Présence d’auto- anticorps anti-leucocytaires. Influence favorable de la splénectomie. Bull. Soc. méd. Hop. Paris 70, 384 (1954).PubMedGoogle Scholar
  5. André, R., B. Dreyfus et M. Bessis: Anticorps anti-leucocytaire dans un cas de leucémie lymphoide. Rev. d’Hématol. 9, 50 (1954).Google Scholar
  6. Ayvazian, L. F., and TH. L. Badger: Disseminated lupus erythematosus occurring among student nurses. New England J. Med. 239, 565 (1948).Google Scholar
  7. Baehr, G., and L. J. Soffer: Treatment of Disseminated lupus erythematosus with cortisone and ACTH. New York Acad. Med. Bull. 26, 229 (1950).Google Scholar
  8. Ballowitz, K., u. L. Ballowitz: Leukocytenveränderungen durch Immunseren in der Knochenmarkkultur. Z. Immun.forsch. 111, 90 (1954).Google Scholar
  9. Baeyer, E. von: Zur Arzneimittel-Agranulocytose. Klin. Wschr. 1936, 1914.Google Scholar
  10. Barbier, F.: La cellule L.E. est-elle spécifique pour le lupus érythémateux aigu disséminé ? Acta med. scand. (Stockh.) 147, 325 (1953).Google Scholar
  11. Barnes, S., T. W. Moffatt, C. W. Lane and R. S. Weiss: Studies on the L.E. phenomenon. Arch, of Dermat. 62, 771 (1950).Google Scholar
  12. Benhamou, ED., A. Albou et P. Griguer: Agranulocytose par sensibillsation au pyramidon, avec leuco-agglutinine hétérophile. Bull. Soc. méd. Hop. Paris 71, 735 (1955).PubMedGoogle Scholar
  13. Berman, L., A. R. Axelrod, H. L. Goodman and R. I. McClaughery: So called “Lupus erythematosus” inclusion phenomenon of bone marrow and blood. Amer. J. Clin. Path. 20, 403 (1950).Google Scholar
  14. Berroche, L., B. Maupin, P. Hervier et J. Dausset: Mise en évidence des antigènes A. et B. dans les leucocytes humains par des épreuves d’absorption et d’élution. Vox Sanguinis 5, 82 (1955).Google Scholar
  15. Bertrand, L.: Les cellules de la lupo-érythémato-viscérite maUgne. Presse méd. 1952, 929.Google Scholar
  16. Besredka: La leucotoxine et son action sur le système leucocytaire. Ann. Inst. Pasteur 14, 390 (1900).Google Scholar
  17. Bessis, M., et J. Tabuis: Action cytologique des sérums anti-leucocytes et anti-plaquettes. Etude par cinématographie en contraste de phase. Rév. d’Hématol. 9, 127 (1954).Google Scholar
  18. Bickel, G., et E. Frommel: La répartition des globules blancs dans les chocs anaphylactique expérimental. J. de Physiol. 22, 625 (1924).Google Scholar
  19. Biedl, A., u. R. Kraus: Experimentelle Studien über Anaphylaxie. Wien. klin. Wschr. 1909, 363.Google Scholar
  20. Bierman, H. R., R. L. Byron, K. H. Kelly and N. L. Petraki: The lung removal mechanism for leukocytes. Blood 6, 770 (1951).Google Scholar
  21. Bock, H. E.: Beiträge zur Physiologie der Blutbüdungsorgane. II. Über Erythro- und Myelopoese im überlebenden Wirbel und Rippenknochenmark. Durchblutungsversuche am isoherten Thorax. Z. exper. Med. 82, 539 (1932).Google Scholar
  22. Bock, H. E.: Über die Pathogenese der Agranulocytose und anderer leukopenischer Zustände. Zbl. inn. Med. 1935, 282.Google Scholar
  23. Bridge, R. G., and F. E. Foley: Placental Transmission of the Lupus erythematosus Factor. Amer. J. Med. Sci. 227, 1 (1954).PubMedGoogle Scholar
  24. Bucher, K., u. H. Staub: Weitere Untersuchungen zum Mechanismus der Leukopenie und Leukocytose nach i.v. Glykogenzufuhr. Arch, exper. Path. u. Pharmakol. 194, 506 (1940).Google Scholar
  25. Bucher, K: Über den Mechanismus der Leukopenie nach i.v. Glykogenzufuhr. Arch, exper. Path. u. Pharmakol. 191, 587 (1939).Google Scholar
  26. Bunting, C. H.: Univ. Penns. Med. Bull. 16, 200 (1903); Zit. nach Lindström.Google Scholar
  27. Cajano, A., J. F. Ross and S. C. Finch: On leukocyte fraction antisera. Int. Haemat. Kongress Paris, 1954.Google Scholar
  28. Cajano, A., e C. Maurea: Sieri Anticellule ed antiorgane. IV Siero anti-midollo osseo. Haematologica (Pavia) 37, 1035 (1953).Google Scholar
  29. Cajano, A., e C. Maurea: Immunizzazione sperimentale del conigho con leucociti leucemici umani. Rivista dell’ Istituto seroterapico Itahano 26, Nr. 2, 1951; Haematologica (Pavia) 34, 1133 (1950).Google Scholar
  30. Capelli, E.: Primi rihevi sul fenomeno deU’autoeritrofagocitosi «in vitro». Raffranto col meccanismo formativo e tentativo d’interpretazione delle cosidette «ceUule del lupus eritematoso ». Minerva dermat. (Torino) 27, Nr. 5 (1952).Google Scholar
  31. Capelli, E.: Basi teoriche e reahzzazione sperimentale «in vitro» del «fenomeno del lupus eritematoso» nel sangue di individui normaM mediante un siero antireticolo-endotelio umano. Minerva dermat. (Torino) 27, Nr. 10 (1952).Google Scholar
  32. Chew, W. B., D. J. Stephens and J. S. Lawrence: Antlleucocytic serum. J. of Immun. 30, 301 (1936).Google Scholar
  33. Chew, W. B., D. J. Stephens: Antiljrmphocytic Serum. J. of Immun. 33, 271 (1937).Google Scholar
  34. Chomet, B., M. M. Kjushen, G. Schaeper and P. Mudrik: The finding of the L.E.-Cells in smears of untreated freshly drawn peripheral blood. Blood 8, 1107 (1953).PubMedGoogle Scholar
  35. Conley, L. C.: Disorders of the blood in disseminated lupus erythematosus. Amer. J. Med. 13, 1 (1952).PubMedGoogle Scholar
  36. Conley, L. C and R. C. Hartmann: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J. Clin. Invest. 31, 621 (1952).Google Scholar
  37. Cruickshank, A. H.: Anti-Lymphocytic Serum. Brit. J. Exper. Path. 22, 126 (1941).Google Scholar
  38. Dameshek, W., and A. Comles: The effect of drugs in the production of agranulocjrtosis with particular reference to amidopjrrine hypersensitivity. J. Clin. Invest. 15, 85 (1936).PubMedGoogle Scholar
  39. Dausset, J., et A. Nenna: Présence d’une leuco-agglutinine dans le sérum d’un cas d’agranulo- cytose chronique. C. r. Soc. Biol. (Paris) 146, 1539 (1952).Google Scholar
  40. Dausset, J., et A. Nenna: Présence d’une leuco-agglutinine dans trois sérums de malades leucopéniques. Sang 24, 410 (1953).PubMedGoogle Scholar
  41. Dausset, J., A. Nenna, H. Tsevrenis et J. Bernard: Leuco-agglutùiines: La pancytopénie chronique idiopathique avec leuco-agglutinine sérique. Rev. d’Hématol. 8, 316 (1953).Google Scholar
  42. Dausset, J: Leuco-agglutinins and bloodtransfusion. Vox Sanguinis 4, 190 (1954).Google Scholar
  43. Dausset, J., A. Nenna and H. Brecy: Leukoagglutinins in chronic idiopathic or symptomatic pancytopenia an in paroxysmal nocturnal hemoglobmiuria. Blood 9, 696 (1954).PubMedGoogle Scholar
  44. Dausset, J: Agranulocytoses et leucopénies par auto-anticorps. Congr. Français de Méd., 30e session Alger, 1955.Google Scholar
  45. Dausset, J: Immuno-hématologie des leucocytes. Vojnosanitetski pregled 12, 3 (1955).Google Scholar
  46. Dausset, J: Présence des antigènes A et B dans les leucocytes, décelée après des épreuves d’agglutination. C. r. Soc. Biol. (Paris) 148, 1607 (1954).Google Scholar
  47. Dausset, J: Immunohämatologisches Kolloquium. Europ. Hämatologenkongreß, Freiburg i. Br. 1955.Google Scholar
  48. Dean, H. R., and R. A. Webb: The blood changes in anaphylactic shock in the dog. J. of Path. 27, 65 (1924).Google Scholar
  49. Delacretaz, J., Th. Inderbitzin et P. Miescher: Les phénomènes pseudo L.E. Schweiz, med. Wschr. 1954, 1103.Google Scholar
  50. Dittrich, H., u. E. Frühmann: Untersuchungen zum Problem der experimentellen Bildung von L.E.-Zellen. Acta haematol. (Basel) 10, 239 (1953).Google Scholar
  51. Doan, CH. A.: The recognition of a biologic differentiation in the white blood cells. J. Amer. Med. Assoc. 86, 1593 (1926).Google Scholar
  52. Doan, CH. A.: Démonstration d’un film sur le phénomène L.E. Symposion sur le système réticuloendothéhal, Gif sur Yvette, 1955.Google Scholar
  53. Doerr, R.: Die Antigene, S. 220 u. ff. Berhn-Göttmgen-Heidelberg: Springer-Verlag 1948.Google Scholar
  54. Dreyfus, B.: Immunohämatologisches Kolloquium, Paris 1955.Google Scholar
  55. Dubois, E. L.: Acquired Hemolytic anemia as the presenting syndrome of lupus erythematosus disseminatus. Amer. J. Med. 12, 197 (1952).PubMedGoogle Scholar
  56. Dubois, E. L.: Effect of quinacrine upon L.E. phenomenon. Arch, of Dermat. 71, 570 (1955).Google Scholar
  57. Eisler, B.: Zur Kausalgenese der Agranulocytose. Klin. Wschr. 1937, 788.Google Scholar
  58. Favour, C. B.: Leucocyte blockade of in vitro tuberculin cytolysis. Proc. Soc. Exper. Biol, a. Med. 70, 369 (1949).Google Scholar
  59. Favour, C. B., P. Fremont-Smith and J. M. Miller: Factors affecting the in vitro cytolysis of white blood cells by tuberculin. Amer. Rev. Tbc. 60, 212 (1949).Google Scholar
  60. Finch, S. C., J. F. Ross and F. G. Ebaugh: Immunologie mechanisms of leucocjrte abnormahties. Labor, a. Clin. Med. 42, 555 (1953).Google Scholar
  61. Foot, N. C.: Über das Verhalten des Hühnerknochenmarkes gegen Iromunplasma in den Zellkulturen nach Carrel. Zbl. Path. 23, 577 (1912).Google Scholar
  62. Francke, E.: Nachweis von Zellgiften im Blut bei Myelophthisen und deren Wirkung auf die Hämatopoese. Klin. Wschr. 1940, 1053.Google Scholar
  63. Frick, P. G.: Acquired circulating anticoagulants in systemic “collagen Disease”. Blood 10, 691 (1955).PubMedGoogle Scholar
  64. Furbetta, D., u. C. A. Buttaro: Aspetti patogenetici e nuove concezioni in tema di agranulocitosi. Riforma med. 62, 96 (1948).PubMedGoogle Scholar
  65. Gasser, C.: Die Pathogenese der essentiellen chronischen Granulocytopenie im Klindesalter auf Grund der Knochenmarksbefunde. Helvet. paediatr. Acta 7, 428 (1952).Google Scholar
  66. Gasser, C. u. M. R. Vrtilek: Essentielle chronische Granulocytopenie im Kondesalter. Schweiz, med. Wschr. 1952, 1122.Google Scholar
  67. Gold, S.: Rôle of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet 1951, 268Google Scholar
  68. Gonyea, L. M., R. A. Kallsen and A. A. Marlow: The occurrence of the L.E. Cell in clotted blood. J. Invest. Dermat. 15, 11 (1950).Google Scholar
  69. Gordon, C., C. Meacham and A. S. Weisberger: Unusual Manifestations of disseminated lupus erythematosus. Ann. Int. Med. 43, 143 (1955).Google Scholar
  70. Gorer, P. A.: The antibody response to skin homografts in Mice. Ann. New York Acad. Sci. 59, 365 (1955).Google Scholar
  71. Goudsmit, R., and J. J. van Loghem: Studies on the occurrence of leuco-antibodies. I.: Vox Sanguinis 3, 3 (1953). II.: Vox Sanguinis 3, 89 (1953).Google Scholar
  72. Griguer, P.: Immunhämatologisches Kolloquium, Paris 1955.Google Scholar
  73. Gsell, O.: Agranulocytosis associated with phenylbutazone therapy. Internat. Record Med. and General Practice Chnics 167, 483 (1954).Google Scholar
  74. Hargraves, M. M., H. Richmond and R. Morton: Presentation of two bone marrow elements: the “tart” cell and the “L.E.” cell. Proc. Staff Meet. Mayo Clin. 23, 25 (1948).PubMedGoogle Scholar
  75. Hargraves, M. M: Production in vitro of the L.E. cell phenomenon. Use of normal marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Proc. Staff Meet. Mayo Clin. 24, 234 (1949).PubMedGoogle Scholar
  76. Hargraves, M. M: The L. E. cell phenomenon. Proc. Staff Meet. Mayo Clin. 27, 419 (1952).PubMedGoogle Scholar
  77. Haserick, J. R.: Plasma L.E. test in systemic lupus erythematosus. Study of twenty-three patients with positive L.E. tests. J. Amer. Med. Assoc. 146, 16 (1951).Google Scholar
  78. Haserick, J. R and D. W. Bortz: PreHminary and short reports. Normal bone marrow inclusion phenomena induced by lupus erythematosus plasma. J. Invest. Dermat. 13, 47 (1949).Google Scholar
  79. Haserick, J. R: Simulation of the lupus erythematosus phenomenon by materials of fungal origin. J. Invest. Dermat. 16, 211 (1951).Google Scholar
  80. Haserick, J. R: Blood Factor in acute disseminated lupus erythematosus: Induction of specific Antibodies against L.E. Factor. Blood 5, 718 (1950).PubMedGoogle Scholar
  81. Hauser, W., u. F. Geier: Chronischer Lupuserythematodes mit akuter Exacerbation und Manifestation am Zentralnervensystem. Nervenarzt 23, 181 (1952).PubMedGoogle Scholar
  82. Henn, M. J., Th. W. Parkin, M. M. Hargraves and M. O. Howard: Acute systemic lupus erythematosus sjntidrome from hydralazine hydrochloride. Arch. Int. Med. 95, 857 (1955).Google Scholar
  83. Hickie, G.: Experimental Observations on chronic Agranulocjrtosis. Quart. J. Med. 17, 165 (1948).PubMedGoogle Scholar
  84. Holst, P. M.: Studies on the effects of tubercuHne. Tubercle 3, 337 (1922).Google Scholar
  85. Heilmeyer, L., u. H. Begemann: Blut- u. Blutkrankheiten. Berlin-Göttingen-Heidelberg: Springer-Verlag 1951.Google Scholar
  86. Hitzig, W. H., A. Labhart u. E. Uehlinger: Transitorische Hemmkörperhämophihe Bei Rheumatismus. Helvet. med. Acta 18, 410 (1951).PubMedGoogle Scholar
  87. Holländer, L., u. P. Miescher: Der heutige Stand der Imimunohämatologie. Praxis (Bern) 44, 65 (1955).Google Scholar
  88. Hueper, W. C., and M. A. Rüssel: The action of antileukocytic serum on tissue cultures. Arch, of Path. 13, 584 (1932).Google Scholar
  89. Inderbitzin, TH.: Zum Problem der Deutung des L.E.-Zell-Phänomens. Acta haematol. (Basel) 12, 268 (1954).Google Scholar
  90. Inderbitzin, TH.: The experimental production of leukocytic changes in normal blood similar to L.E.-cells and morphologically identical with L.E. cells. J. Invest. Dermat. 20, 67 (1953).Google Scholar
  91. Inderbitzin, TH.: Experimentelle Untersuchungen zur Frage der Genese der sog. L.E.-Zelle. Acta haematol. (Basel) 10, 31 (1953).Google Scholar
  92. Jacobs, A. G.: A falso-positive L.E. Test. Ann. Int. Med. 42, 1097 (1955).PubMedGoogle Scholar
  93. Jasmski, B., G. E. Stiefel, M. Märki u. F. Wuhrmann: Über ein dem L.E.-Phänomen ähnliches Zellbild im Cantharidenblaseninhalt xmd seine Beziehungen zu den Gamma- GlobuHnen. Klin. Wschr. 1953, 252.Google Scholar
  94. Jasmski, B.: Das Verhalten der Retikulumzellen des Knochenmarkes in akut einsetzenden Granulocytopenien tmd Agranulocytosen. Schweiz, med. Wschr. 1944, 497.Google Scholar
  95. Klein, E.: Lupus erythematodes visceralis sive disseminatus. Dtsch. med. Wschr. 1955, 226.Google Scholar
  96. Klemperer, P.: The concept of collagen Diseases. Amer. J. Path. 26, 505 (1950).PubMedGoogle Scholar
  97. Klemperer, P., B. Gueft, S. L. Lee, C. Leuchtenberger and K. W. Pollister: Cytochemical changes of acute lupus erythematosus. Arch, of Path. 49, 503 (1950).Google Scholar
  98. Klemperer, P.: The pathogenesis of lupus erythematosus and allied conditions. Ann. Int. Med. 28, 1 (1948).PubMedGoogle Scholar
  99. Kinsell, L. W., L. M. Kopeloff, R. L. Zwemer and N. Kopeloff: Blood constituents during anaphylactic shock in the monkey. J. of Immun. 42, 35 (1941).Google Scholar
  100. Kissmeyer-Nielsen, F., J. Bichel and P. Bjerre-Hansen: Experimental Investigations on the pathogenesis of non-leukemic and leukemic leukopenia. Acta med. scand. (Stockh.) 150, 349 (1954).Google Scholar
  101. Kissmeyer-Nielsen, F.: Demonstration of a thrombocytopenic and an leucopenic factor in the blood of patients with thrombocytopenia and leucopenia. Acta haematol. (Basel) 9, 337 (1953).Google Scholar
  102. Kracke, R. R., and F. P. Parker: The etiology of granulopenia with particular reference to the. drugs containing the benzene ring. J. Labor, a. Clin. Med. 19, 799 (1934).Google Scholar
  103. Kracke, R. R.: Recurrent Agranulocytosis. Report of an unusual case. Amer. J. Clin. Path. 1, 385 (1931).Google Scholar
  104. Kracke, R. R.: Relation of drug-therapy to neutropenic states. J. Amer. Med. Assoc. 111, 1255 (1938).Google Scholar
  105. Kjrauel, G.: Beitrag zur Experimentellen Agranulocytose. Klin. Wschr. 1937, 1245.Google Scholar
  106. Kurnick, N. B., S. Pariser, L. I. Schwartz, S. L. Lee u. W. Irvine: Studies on Desoxyribonuclease in systemic lupus erythematosus. Non participation of serum desoxyribo- nuclease in the L.E. phenomenon. J. Clin. Invest. 31, 1036 (1952).PubMedGoogle Scholar
  107. Kurnick, N. B., L. Schwartz, S. Pariser, S. Lee and W. Irvine: The rôle of desoxyribonuclease and a nuclease inhibitor from leucocytes in the lupus erythematosus ceU phenomenon. J. Clin. Invest. 31, 645 (1952).Google Scholar
  108. Kurnick, N. B., L. Schwartz, S. Pariser, S. Lee and W. Irvine: Specific inhibitor for human desoxyribonuclease and an inhibitor of the L.E. phenomenon from leucocytes. j. Clin. Invest. 32, 193 (1953).Google Scholar
  109. Lanmann, J. T., H. R. Bierman and R. L. Byron: Transfusion of leucemie leukocytes in man. Blood 5, 1099 (1950).Google Scholar
  110. Lasch, F.: Experimentelle Untersuchungen über die Allergie der Pyramidon-Agranulocytose. Münch, med. Wschr. 1940, 821.Google Scholar
  111. Ledingham, J. C., and S. P. Bedson: Experimental purpura. Lancet 1915 1, 311.Google Scholar
  112. Lee, S. L.: A simple test for L.E. cells. Amer. J. Clin. Path. 21, 492 (1951).Google Scholar
  113. Lee, S. L., S. R. Michael and I. L. Vural: The lupus erythematosus cell. Bull. New York Acad. Med. 26, 266 (1950).Google Scholar
  114. Lee, S. L., S. R. Michael and I. L. Vural: The L.E. cell. Chnical and chemical studies. Amer. J. Med. 10, 446 (1951).PubMedGoogle Scholar
  115. Leoni, A.: A proposito della specificità del fenomono L. E. Minerva med. Acta 45, 1 (1954).Google Scholar
  116. Ley, A. B., G. G. Reader, C. W. Sorenson and R. S. Overman: Idiopathic hypoprothrombinemia associated with hemorrhagic diathesis, and the effect of vitamin K. Blood 6, 740 (1951).PubMedGoogle Scholar
  117. Lindström, G. A.: An experimental study of myelotoxic sera. Therapeutic attempts in myeloid leukemia. Acta med. scand. (Stockh.), suppl. 22 (1927).Google Scholar
  118. Madison, F. W., and T. L. Squier: The etiology of primary granulocytopenia (agranulocytic angina). J. Amer. Med. Assoc. 102, 755 (1934).Google Scholar
  119. Madison, F. W., and T. L. Squier: Primary granulocytopenia after administration of drugs containing a benzene chain. Presented at annual meeting central Soc. for Clinical Research, Chicago, 1933; zit. nach Dameshek u. Colmes.Google Scholar
  120. Magath, TH. B., and V. Winkle: Technic for demonstrating L.E. cells in blood. Amer. J. Clin. Path. 22, 586 (1952).Google Scholar
  121. Mahaux, J., R. Denolin-Reubens et PH. Mascart: Les caractères biologiques du lupus érythémateux aigu disséminé. Modifications du protéinogramme électrophorétique et cellules du lupus. Rev. d’Hématol. 8, 77 (1953).Google Scholar
  122. Marmont, A.: Value and Limitations of the L.E. Cell test in the syndrome known as systemic lupus erythematosus without skin eruptions. Acta haematol. (Basel) 13, 257 (1955).Google Scholar
  123. Marmont, A.: Observations et remarques sur le phénomène L.E.: C. r. VIII e Congrès des dermatologistes et syphiHgraphes de langue française, 1953 (Nancy-Vittel).Google Scholar
  124. Marmont, M. A.: Le cosidette angiomesenchimopatie reattive diffuse. Correlazione al 52. Congr. Soc. Ital. Med. Int. Pozzi, Roma, 1951.Google Scholar
  125. Marmont, A.: Beobachtungen über das sogenannte L.E.-Phänomen. Schweiz, med. Wschr. 1952, 1111.Google Scholar
  126. Marmont, A.: Immunoematologia. Attuahtà in ematologia. Roma; Abruzzüii Editore 1955.Google Scholar
  127. Martbnsson, J., and I. Vikbladh: Idiopathic immunoneutropenia. Report of a case with a leukocyte agglutinating factor in the serum. Blood 9, 632 (1954).Google Scholar
  128. Marti, H. R., A. F. Esselibr u. L. Morandi: Zur Antigenanalyse eosinophiler Granulocyten. Schweiz. Z. allg. Path. 17, 468 (1954).PubMedGoogle Scholar
  129. Marti, H. R., A. F. Esselibr u. L. Morandi: Serologische Untersuchungen an eosinophilen Leukocyten. Schweiz. Z. allg. Path. 16, 910 (1953).PubMedGoogle Scholar
  130. Matsuno, M.: Über den Einfluß des Antikaninchenleukocytenserums auf die Phagocytose. Tohoku J. Exper. Med. 19, 168 (1932).Google Scholar
  131. Mauriac, P., et M. Moureau: La fragilité leucocytaire. Recherches cliniques et expérimentales. J. Méd. franç. 9, 243 (1920).Google Scholar
  132. Metschnikoff, E.: Sur les cytotoxines. Ann. Inst. Pasteur 13, 737 (1899); 14, 369 (1900).Google Scholar
  133. Michael, S. R., I. L. Vural, F. A. Bassen and L. Schaefbr: The hematologic aspects of disseminated lupus erythematosus. Blood 6, 1059 (1951).PubMedGoogle Scholar
  134. Miescher, P.: Immimophagocytose des éléments cellulaires dans le sang. Schweiz, med. Wschr. 1953, 216.Google Scholar
  135. Miescher, P.: Leucopénie chronique par auto-anticorps. Helvet. med. Acta 20, 420 (1953); Acta haematol. (Basel) 11, 152 (1954).Google Scholar
  136. Miescher, P.: Immunpancytopenie. Verh. dtsch. Ges. inn. Med. 60, 262 (1954).Google Scholar
  137. Miescher, P.: Leucopénies et agranulocytoses d’origine immunologique. Sang 26, 71 (1955).PubMedGoogle Scholar
  138. Miescher, P.: Mise en évidence.du facteur L.E. par la réaction de consommation d’anti-globuline. Vox. Sanguinis 5, 121 (1955).Google Scholar
  139. Miescher, P et J. Delacrétaz: Démonstration d’un phénomène „L.E.“ positif dans deux cas d’hyper- sensibihté médicamenteuse. Schweiz, med. Wschr. 1953, 356.Google Scholar
  140. Miescher, P., M. Fauconnet and TH. Béraud: Immunonucléophagocytose expérimentale et phénomène L.E. J. Exper. Med. 11, 173 (1953).Google Scholar
  141. Miescher, P., M. Fauconnet.: Mise en évidence de différents groupes leucocytaires chez l’homme. Schweiz, med. Wschr. 1954, 597.Google Scholar
  142. Miescher, P., A. Miescher u. M. Fauconnet: Immunophagocytose der Blutzellen in vitro. Dtsch. med. Wschr., Allergie-Beilage 1954, 9.Google Scholar
  143. Miescher, P., M. Fauconnet: L’absorption du facteur „L.E.“ par des noyaux cellulaires isolés. Experientia (Basel) 10, 252 (1954).Google Scholar
  144. Miescher, P., M. Fauconnet: Les constituants antigéniques du leucocjrfce polynucléaire et leur importance chnique. Schweiz, med. Wschr. 1954, 1036.Google Scholar
  145. Miescher, P., L. Holländer: Les hémopathies par „auto-anticorps“. Rev. méd. Suisse rom. 75, 398 (1955).PubMedGoogle Scholar
  146. Miller, J. M., C. B. Favour, B. A. Wilson and M. A. Umbarger: A plasma factor responsible for in vitro lysis of leucocytes by tuberculoprotein. J. Proc. Soc. Exper. Biol. a. Med. 70, 738 (1949).Google Scholar
  147. Miller, J. M., C. B. Favour, B. A. Wilson and M. A. Umbarger: Nature of the plasma factor responsible for in vitro lysis of leucocytes by tuberculoprotein. Proc. Soc. Exper. Biol. a. Med. 71, 287 (1949).Google Scholar
  148. Moeschlin, S., and K. Wagner: Agranulocytosis due to the occurrence of leukocyteagglutmms. Acta haematol. (Basel) 8, 29 (1952).Google Scholar
  149. Moeschlin, S., and K. Wagner: Leukocytenagglutinine als Ursache von Agranulocytosen. Schweiz, med. Wschr. 1952, 1104.Google Scholar
  150. Moeschlin, S.: Die SuHapyridin-Agranulocytose als Immuno-Leukopenie. Verh. dtsch. Ges. inn. Med. 60, 253 (1954).Google Scholar
  151. Moeschlin, S.: Weitere Beobachtungen über Immunoleukopenien und -agranulocytosen. Schweiz, med. Wschr. 1954, 1100.Google Scholar
  152. Moeschlin, S., R. Moreno: Pyramidon-Agranulocytose mit Agglutininen für arteigene und artfremde Leukocyten. Klin. Wschr. 1954, 799.Google Scholar
  153. Moeschlin, S.: Immunological agranulocytosis. Sang 25, 679 (1954); Rev. d’Hématol. 8, 249 (1953).PubMedGoogle Scholar
  154. Moeschlin, S.: Immunological Granulocytopenia and agranulocytosis, clinical aspects. Sang 26, 1 (1955).Google Scholar
  155. Moeschlin, S., W. Sibgenthaler, C. Gasser and A. Hässig: Immuno-pancytopenia assiocated with incomplete cold hemagglutinins in a case of primary atypical pneumonia. Blood 9, 214 (1954).PubMedGoogle Scholar
  156. Moeschlin, S., E. Schmid: Investigation of leukocyte agglutination in serum of compatible and incompatible blood groups. Acta haematol. (Basel) 11, 241 (1954).Google Scholar
  157. Moeschlin, S., H. Meyer, L. G. Israels and E. Tarr-Gloor: Experimental Agranulocytosis. Its production through leukocyte agglutination by antileukocytic serum. Acta haematol. (Basel) 11, 73 (1954).Google Scholar
  158. Moffat, TH. W., S. S. Barnes and R. S. Weiss: The induction of the L.E. cell in normal peripheral blood. J. Invest. Dermat. 14, 153 (1950).Google Scholar
  159. Moulinier, J.: Immunohämatologisches Kolloquium, Europ. Hämatologenkongreß, Freiburg i. Br. 1955. 182Google Scholar
  160. Moyer, J. B., and G. S. Fisher: Experimental Production of L.E. Cells. Amer. j. Clin. Path. 20, 1011 (1950).Google Scholar
  161. Müller, W., u. J. Weinreich: Über die Pathogenetische Bedeutung von Antikörpern bei einigen Pancytopenieformen. Klin. Wschr. 1954916.Google Scholar
  162. Müller, W., u. J. Weinreich: Zur Pathogenese der Arzneimittelagranulocylose. Acta haematol. (Basel) 12, 304 (1954).Google Scholar
  163. Niekau, B.: Agranulocytose nach längerem Gebrauch pyramidonhaltiger Arzneimittel. Verh. dtsch. Ges. inn. Med. 47, 219 (1935).Google Scholar
  164. Ninni, M.: Importanza biologica deUe „leucohsine“. Progresso Medico 6, 640 (1950).Google Scholar
  165. Oliva, G., e D. Furbetta: Attività leucohtica del siero di sangue nell agranulocitosi. Boll. Soc. ital. Biol. sper. 19, 234 (1944).Google Scholar
  166. Oliva, G., e D. Furbetta: Ancora sull attività leucohtica del plasma nell’agranulocitosi e sulla peculare „resistenza“ delle forme bianche immature. Haematol. Arch. 29, 489 (1946).Google Scholar
  167. Pepper, O. H. P.: Leukopenia. A review; with special reference to agranulocytotic angina. Cahfornia and West. Med. 35, 82 (1931).Google Scholar
  168. Petrides, P.: Nebenwirkungen der modernen medikamentösen Therapie mit besonderer Berücksichtigung der allergischen Reaktionen. Verh. dtsch. Ges. inn. Med. 60, 457 (1954).Google Scholar
  169. Petrides, P.: Neuzeithehe Gesichtspunkte der Therapie allergischer Kjiochenmarksschäden. Fortschr. mn. Med. 71, 329 (1953).Google Scholar
  170. Petrides, P.: Das Arthus Phaenomen des Knochenmarks. Beitrag zur Klinik anaphylaktischer Knochenmarksschäden. Schweiz, med. Wschr. 1950, 1114.Google Scholar
  171. Perry, H. M., and H. A. Schroeder: Syndrome simulating collagen disease caused by Hydralazine. J. Amer. Med. Assoc. 154, 670 (1954).Google Scholar
  172. Pirquet, C. F. von, u. B. Schick: Die Serumkrankheit. Leipzig u. Wien: Franz Deuticke 1905.Google Scholar
  173. Pisciotta, A. V., J. J. Giliberti, J. J. Greenwalt and W. W. Engstrom: Acute hemolytic anemia in disseminated lupus erythematosus. Amer. J. Clin. Path. 21, 1138 (1951).Google Scholar
  174. Plum, P.: Agranulocytose und Amidopyrin, experimentell beleuchtet. Verh. dtsch. Ges. inn. Med. 47, 208 (1935).Google Scholar
  175. Rasponi, L.: Sulla questione della specificità del fenomeno L.E. Giorn. ital. Dermat. 1955, 1.Google Scholar
  176. Rechenberg, K. H. von: Butazohdin and Irgapyrin in their relations to agranulocytosis. Acta haematol. (Basel) 9, 354 (1953).Google Scholar
  177. Rejholec, V., L. Donner, V. Wagner u. Z. Mandlikova: O nekterych antigennich vlastnostech leukocytu. Cas. Lek. Cesk. 10, 242 (1954).Google Scholar
  178. Rich, A. R., and M. R. Lewis: The nature of allergy in tuberculosis as revealed by tissue culture studies. Bull. Johns Hopkins Hosp. 50, 115 (1932).Google Scholar
  179. Rocha, E., Silva, M.: The role played by leucocytes and platelets in anaphylactic and peptone shock. Ann. New York Acad. Sci. 50, 1045 (1950).Google Scholar
  180. Rocha E Silva M., A. E. Scroggie, E. Fidlar and L. B. Jaques: Libertation of histamin and heparin by peptone from the isolated dog’s hver. Proc. Soc. Exper. Biol. a. Med. 64, 141 (1947).Google Scholar
  181. Roberts, St. R., and R. R. Kracke: Agranulocytosis. Report of a case. J. Amer. Med. Assoc. 95, 780 (1930).Google Scholar
  182. Röhn, R. J., and W. H. Bond: Some supravital observations on the L.E. phenomenon. Amer. J. Med. 12, 422 (1952).PubMedGoogle Scholar
  183. Rohr, K.: Der heutige Stand der Agranulocytoseforschung. Helvet. med. Acta 6, 611 (1939).Google Scholar
  184. Rohr, K.: Das menschhche Knochenmark. Stuttgart: Georg Thieme 1949.Google Scholar
  185. Ruggieri, P., et A. Ferrara: Les leucoagglutinines dans l’aplasie myéloide. Internat. Haemat. Kongress Paris 1954.Google Scholar
  186. Rutledge, B. H., O. C. Hansen-Pruss and W. S. Thayer: Recurrent Agranulocytosis. Bull. Johns Hopkins Hosp. 46, 369 (1930).Google Scholar
  187. Schilling, V.: Diskussionsvortrag Verh. Dtsch. Ges. inn. Med. 47, 198 (1935).Google Scholar
  188. Schilling, V.: Das Knochenmark als Organ. Dtsch. med. Wschr. 1925, 261, 344, 467, 516, 598.Google Scholar
  189. Schmidt, W., u. S. Moeschlin: Physikalisch-chemische imd serologische Untersuchungen von Antüeukocytenserum. Ärztl. Forsch. 8, 229 (1954).Google Scholar
  190. Schultz, W.: Gangräneszierende Prozesse imd Defekt des Granulocytensystems. Dtsch. med. Wschr. 1922, 1495.Google Scholar
  191. Schuppli, R.: Untersuchungen über die allergische Leukopenie. 1. Internat. Allergie-Kongreß, Zürich, S. 744. Basel: S. Karger 1951.Google Scholar
  192. Schwartz, R. S., and W. K. Hass: Leucoagglutinins in agranulocytosis. Arch. Int. Med. 95, 863 (1955).Google Scholar
  193. Schwartz, G.: Eine neue Methode des Antikörpernachweises bei Arzneimittelallergien. Dtsch. Arch. Min. Med. 197, 417 (1950).Google Scholar
  194. Seligmann, M., P. Grabar et J. Bernard: Etudes sur la constitution antigénique des leucocytes normaux et leucémiques par les méthodes de précipitation spécifique en miheu géhfié. Sang 26, 52 (1955).PubMedGoogle Scholar
  195. Seligmann, M., P. Grabar et J. Bernard: Leucoprecipitins. Presence of precipitating antüeucocyte antibodies in the serum of patients with acute leukemia. Vox Sanguinis 4, 181 (1954); Presse méd. 1954, 1700.Google Scholar
  196. Seitz, R., u. R. Jürgens: Agranulocytose durch Schlafmittel. Tagung der Nordwestdeutschen Gesellschaft f. Inn. Med. Göttingen/Kassel, 1955.Google Scholar
  197. Snapper, I., and D. Nathan: The mechanism of the L.E. cell phenomenon, studied with a simphfied test. Blood 10, 718 (1955).PubMedGoogle Scholar
  198. Soffer, L. J., M. F. Levitt and G. Baehr: Use of cortisone and ACTH in acute disseminated L.E. Arch. Int. Med. 86, 558 (1950).Google Scholar
  199. Slocumb, Ch. H.: Rheumatic Complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc. Staff Meet. Mayo Clin. 28, 655 (1951).Google Scholar
  200. Staub, H., u. K. Bucher: Zum Mechanismus der Leukopenie nach i.v. Glykogenzufuhr. Schweiz, med. Wschr. 1943, 904.Google Scholar
  201. Staub, H., u. K. Bucher: Über den Mechanismus der Leukopenie nach i.v. Glykogenzufuhr. Klin. Wschr. 1938, 1555.Google Scholar
  202. Steffen, C.: Immunohämatologisches Kolloquium, Europ. Hämatologenkongreß, Freiburg 1955.Google Scholar
  203. Steinberg, B., and R. A. Martin: Leukoagglutination differentiation of normal leukocytic and leukemic cell-types. J. of Immun. 52, 71 (1946).Google Scholar
  204. Steinberg, B., and R. A. Martin: Differentiation of some disorders of the lymphatic system by leukoagglutination. J. of Immun. 52, 137 (1946).Google Scholar
  205. Steinberg, B., and R. A. Martin: Agglutination of circulating leukocytes by antileukocytic sera. Proc. Soc. Exper. Biol. a. Med. 56, 50 (1944).Google Scholar
  206. Steinberg, B., and R. A. Martin: Factors influencing leukoagglutination by antileukocytic sera. J. of Immun. 51, 421 (1945).Google Scholar
  207. Suksta, A., and C. Lockard: Some observations on the L.E. Cell. J. Labor, a. Clin. Med. 37, 597 (1951).Google Scholar
  208. Sundberg, R. D., and N. B. Lick: L.E. Cells in the blood in acute disseminated L.E. J. Invest. Dermat. 12, 83 (1949).Google Scholar
  209. Thomson, O.: Recherches sur la differentiation des groupes serologiques dans les leucocytes. C. r. Soc. Biol. (Paris) 104, 499 (1930).Google Scholar
  210. Twible, E. A., J. L. Tullis and L. K. Diamond: In Tullís, blood cells and plasma proteins; their state in nature. New York: Acad. Press 1953.Google Scholar
  211. Verloop, M. C.: Some observations concerning the L.E. phenomenon. Acta med. scand. (Stockh.) 148, 183 (1954).Google Scholar
  212. Waksman, B. H.: Specific white cell lysis produced by combination of rabbit antiserum to purified protein with homologous antigen. J. of Immun. 70, 331 (1953).Google Scholar
  213. Walsh, J. R., and R. L. Egan: The reliabüity of the L.E. test. New England J. Med. 246, 775 (1952).Google Scholar
  214. Walsh, J. R., H. J. Zimmerman: The demonstration of the L.E. phenomenon in patients with peniciUin hypersensitivity. Blood 8, 65 (1953).PubMedGoogle Scholar
  215. Waser, P., u. W. Hunzinger: Über die Fixierung von hochmolekularen Kohlenhydraten in der Lunge. Experientia (Basel) 7, 226 (1951).Google Scholar
  216. Watkins, C. H.: The possible role of barbiturates and amidopyrine in causation of leukopenic states. Proc. Staff. Meet. Mayo Clin. 8, 713 (1933).Google Scholar
  217. Webb, R. A.: The mechanism of anaphylactic leucopenie in dogs. J. of Path. 27, 79 (1924).Google Scholar
  218. Weisberger, A. S., and R. W. Heinle: Mechanisms responsible for the inability to transfuse leucocytes. Blood 6, 771 (1951).Google Scholar
  219. Weisberger, A. S., G. C. Meacham and R. Heinle: Simple method for demonstrating the L.E. phenomenon in peripheral blood. J. Labor, a. Clin. Med. 39, 480 (1952).Google Scholar
  220. Weiss, H., u. J. Tsuru: Über den Einfluß des anaphylaktischen Schockes auf das Blut. Z. Immun.forsch. 5, 516 (1910).Google Scholar
  221. Weiss, R. S., and SH. Swift: The significance of a positive L.E. phenomenon. Arch, of Dermat. 72, 103 (1955).Google Scholar
  222. Wiard, B. A., and S. L. Bobbins: Hypersplenism. A case report with postmortem study. Blood 7, 631 (1952).PubMedGoogle Scholar
  223. Wichels, P., u. W. Lampe: Die gruppenspezifische Differenzierung der Leukocyten. Klin. Wschr. 1928, 1741.Google Scholar
  224. Widal, F., P. Abrami et ET. Brissaud: Phénomènes de choc. Signification de l’hémoclasie. Presse méd. 1920, 181.Google Scholar
  225. Widal, F., P. Abrami, ET. Brissaud, R. Bénard et E. Joltrain: Les modifications de l’indice réfractométrique des sérums, au cours des crises hémoclasiques. C. r. Soc. Biol. (Paris) 77, 280 (1914).Google Scholar
  226. Widal, F., P. Abrami, ET. Brissaud, E. Joltrain: Réactions d’ordre anaphylactique dans l’urticaire. La crise hémoclasique initiale. Bull. Soc. méd. Hop. Paris 37, 256 (1914).Google Scholar
  227. Wintrobe, M. M.: Clinical Hematology. London: Henry Kimpton, Ed. 1951.Google Scholar
  228. Wittkower, E.: Die Veränderungen des Blutes bei der Anaphylaxie. Z. exper. Med. 34, 108 (1923).Google Scholar
  229. Yamamoto, H.: Tohoku J. Exper. Med. 15, 324, 1930; zit. aus Matsuno.Google Scholar
  230. Zimmer, F. E., and M. M. Hargraves: The effect of blood coagulation on L.E. formation. Proc. Staff Meet. Mayo Clin. 27, 424 (1952).PubMedGoogle Scholar
  231. Zimmermann, H. J., J. R. Walsh and P. Heller: Production of Nucleophagocytosis by rabbit antileukocytic serum. Blood 8, 651 (1953).Google Scholar
  232. Zollinger, H.: Pathologen-Kongreß. Zürich 1955.Google Scholar
  233. Zoutendyk, A.: Autoantibodies in the pathogenesis of disease. A preliminary study of autosensitization of red cells in various diseases. S. Airic. Med. J. 25, 665 (1951).Google Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1956

Authors and Affiliations

  • P. Miescher
    • 1
  1. 1.Medizinischen Universitäts-PoliklinikBaselSwitzerland

Personalised recommendations